Irisin establishes its anti-obesity effects by imposing a BAT-like phenotype upon WAT, upregulating the ability of WAT to expend energy via enhancing mitochondrial density and increasing UCP1 expression (Huh et al. 2012). This evidence concerns the gene UCP1 and obesity due to melanocortin 4 receptor deficiency.